SDI Group Regulatory News (SDI)

Scientific Digital Imaging plc

("SDI", the "Company" or the "Group")

(AIM: SDI)

Directorate Change

The Board of Scientific Digital Imaging plc, the AIM quoted group focused on the design and manufacture of scientific and technology products for use by the life science, healthcare, astronomy, consumer manufacturing and art conservation markets, announces that, Jeremy Gibbs, Non-Executive Director, will be stepping down from the Board on 30 April 2017, having served on the Board for over 8 years after a long association with a subsidiary company.

In addition, the Company is pleased to announce the appointment of Isabel Napper as a Non-Executive Director with immediate effect.

Isabel has more than 25 years' experience in advising clients in the technology and healthcare/life science areas, both public and private sector, leading on business development and managing regulatory issues, governance, risk and strategic change. Isabel was previously a Partner at the law firm Mills & Reeve where she acted as legal adviser and company secretary to a number of boards.

Ken Ford, Chairman of SDI, commented:

"On behalf of the Board, I would like to thank Jeremy for his valuable contribution to SDI over the last two decades. We wish him well for the future. We are pleased to welcome Isabel Napper to the Board. Isabel brings a wealth of experience and knowledge and this will be a valuable addition for us in the Company's future development."

Enquiries

Scientific Digital Imaging plc 01223 727144

Ken Ford, Chairman

Mike Creedon, CEO

www.scientificdigitalimaging.com 

finnCap Ltd 020 7220 0500

Ed Frisby/Simon Hicks - Corporate Finance

Mia Gardner- Corporate Broking

JW Communications 07818 430877

Julia Wilson - Investor & Public Relations

About SDI:

Scientific Digital Imaging plc designs and manufactures scientific and technology products for use in applications including life sciences, healthcare, astronomy, consumer manufacturing and art conservation. SDI intends to continue to grow through its own technology advancements as well as strategic, complementary acquisitions.

Regulatory Disclosures

The following disclosures are required regarding Isabel's appointment pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies:

Current directorships and partnerships:

Emmaus Cambridge

Health Enterprise East Limited

Eastern Academic Health Science Network

Past directorships and partnerships held over the last 5 years:

Mills & Reeve LLP

Full Name: Isabel Josephine Sutherland Napper

Previous Names: Isabel Josephine Sutherland Pokorny

Isabel Josephine Sutherland Robinson

Age: 59

Isabel has no shareholding in the Company.

No further disclosure is required under AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies with respect to Isabel Napper.